Condoms treated with silver nanoparticles could ‘completely inactivate’ HIV, other STDs: researchers

Canadian researchers say they have found a solution to the humble condom’s fatal flaw: nanoparticles.

Condoms have a 15% failure rate, so a University of Manitoba team tried soaking condoms in a solution packed with “remarkable,” microscopic silver nanoparticles, and the treated devices appeared to kill all HIV and herpes in lab experiments, the scientists report.

“Till now, there has been no single condom with additional protection against sexually transmitted infections available on the market,” noted the group’s paper just published in the International Journal of Nanotechnology. But when their novel nanoparticle condoms contacted HIV, “the infectiousness of the virus could be completely inactivated.”

It has long been known that silver has disinfectant powers, prompting people in the early 1900s to put it in milk to stave off spoilage, and in eye drops to try to prevent infection. Its effectiveness, though, was less than reliable.

Read More

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below